Investments Sought
acquisitions. Minority equity. Equity-Enhanced bridge loans
Recurrent Capital specializes in acquiring cash-flow-positive or breakeven private companies with stable to growing revenues, with variable size ranges considered. Recurrent Capital has deep experience in 'roll-ups' and is always on the lookout for strong roll-up opportunities.
Recurrent Capital is open to non-control equity investments in cash flow positive and break even companies, as well as select earlier stage companies demonstrating exceptional growth potential. We do not engage in or consider any company loans requiring a lending license, nor do we extend loans to individuals. Any bridge loans provided must serve as a genuine bridge: short-term, backed by assets, and with a clear, high-confidence exit strategy. It's important to note that our business model focuses on equity rather than interest income, thus bridge loans must be equity-enhanced. Recurrent Capital does not consider any debt instrument that requires a lending license. Recurrent Capital will not invest in the following types of companies: biotech, retail, cannabis, distribution or any non-US companies, with the exception of Israel and Canada. Please email us with any questions on specific transactions.